Clinical Trials Logo

PULSE WAVE VELOCITY clinical trials

View clinical trials related to PULSE WAVE VELOCITY.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03415880 Completed - Diabetes Mellitus Clinical Trials

Light Intensity Physical Activity Trial

LiPAT
Start date: November 8, 2018
Phase: N/A
Study type: Interventional

In type 2 diabetes (T2D), physical activity is an important modifiable risk factor of cardiovascular disease (CVD). Unfortunately (long-term) compliance to exercise programs in patients with T2D is poor. Light-intensity physical activity (LiPA) such as walking slowly, household activities or taking a flight of stairs might be a potential target for lowering the CVD risk in patients with T2D since it can perhaps be more be incorporated into daily life. To assess cardiovascular disease risk in this single-blinded RCT, the investigators settled on measuring arterial stiffness as the primary outcome. Arterial stiffness has independent predictive value for cardiovascular events and can be measured reliably and non-invasively. The investigators hypothesize that light intensity physical activity intervention program based upon increasing LiPA by replacing sedentary time is effective in lowering arterial stiffness as estimated by aortic pulse wave velocity (PWV) and carotid distensibility in individuals with T2D.

NCT ID: NCT01472692 Completed - Hypertension Clinical Trials

Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure

Start date: October 2011
Phase: Phase 4
Study type: Interventional

High normal blood pressure, also called prehypertension, is a significant problem. High uric acid in the blood, the same thing that causes gout, may cause higher blood pressures. The investigators plan to monitor the effects of the drug febuxostat(trade name Uloric) on blood pressure and stiffness of the main blood vessels and see if lowering uric acid has any effect.